Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,455	2,125	2,883	2,283	1,987	1,479
Short-Term Investments	42.57	61.7	40.61	109.64	-	-
Trading Asset Securities	-	-	-	-	-	43.52
Cash & Short-Term Investments	1,497	2,187	2,923	2,393	1,987	1,523
Cash Growth	-26.63%	-25.19%	22.16%	20.40%	30.49%	0.17%
Accounts Receivable	2,716	2,653	2,725	1,971	1,971	1,797
Other Receivables	193.38	34.1	60.77	40.73	36.63	11.44
Receivables	2,910	2,687	2,785	2,011	2,007	1,809
Inventory	1,631	1,567	1,429	1,525	1,488	1,595
Other Current Assets	1,085	111.07	107.5	495.77	121.13	208.64
Total Current Assets	7,122	6,552	7,245	6,425	5,604	5,135
Property, Plant & Equipment	1,454	1,442	1,465	1,486	1,460	1,367
Long-Term Investments	929.88	882.67	801.46	740.74	803.85	906.91
Goodwill	65.91	65.91	84.69	-	-	-
Other Intangible Assets	305.1	317.75	281.13	198.19	202.51	174.06
Long-Term Deferred Tax Assets	301.86	265.99	208.35	154.6	165.48	183.8
Long-Term Deferred Charges	6.37	18.3	17.54	4.72	8.81	8.29
Other Long-Term Assets	784.87	686.29	53.77	57.51	39.47	67.97
Total Assets	10,970	10,230	10,157	9,067	8,283	7,843
Accounts Payable	991.88	1,126	1,406	1,242	902.25	652.64
Accrued Expenses	299.78	1,493	1,170	679.77	709.16	790.64
Short-Term Debt	1,023	81.8	101.64	-	-	-
Current Portion of Long-Term Debt	42.04	-	-	30	-	-
Current Portion of Leases	-	3.56	4.1	1.6	1	0.96
Current Income Taxes Payable	156.64	76.68	93.28	9.53	10.49	59.36
Current Unearned Revenue	63.51	145.66	219.07	215.61	246.67	364.3
Other Current Liabilities	1,615	305.66	339.37	254.89	294.27	289.29
Total Current Liabilities	4,192	3,233	3,333	2,434	2,164	2,157
Long-Term Debt	214.97	251.03	161.3	10	40	40
Long-Term Leases	2.33	2.74	0.87	1.57	1.71	2.71
Long-Term Unearned Revenue	55.96	57.14	59.88	59.15	63.35	44.94
Long-Term Deferred Tax Liabilities	7.03	7.33	8.82	4.21	3.8	8.94
Other Long-Term Liabilities	43.43	33.69	40.73	44.42	60.78	66.17
Total Liabilities	4,516	3,585	3,605	2,553	2,333	2,320
Common Stock	770.16	770.16	773.44	773.44	773.64	772.8
Additional Paid-In Capital	975.57	975.21	1,048	1,374	1,365	1,349
Retained Earnings	4,646	4,828	4,700	4,218	3,681	3,209
Treasury Stock	-5.39	-7.04	-29.75	-32.03	-34.78	-28.3
Comprehensive Income & Other	33.66	34.34	29.53	30.62	23.19	86.18
Total Common Equity	6,420	6,601	6,521	6,364	5,808	5,388
Minority Interest	33.82	44.55	30.49	149.35	141.49	135.03
Shareholders' Equity	6,454	6,645	6,552	6,514	5,950	5,523
Total Liabilities & Equity	10,970	10,230	10,157	9,067	8,283	7,843
Total Debt	1,283	339.14	267.91	43.17	42.71	43.67
Net Cash (Debt)	214.58	1,848	2,655	2,350	1,945	1,479
Net Cash Growth	-83.07%	-30.41%	13.01%	20.83%	31.46%	17.55%
Net Cash Per Share	0.28	2.40	3.42	3.05	2.53	1.92
Filing Date Shares Outstanding	770.16	770.16	773.44	773.44	773.64	772.8
Total Common Shares Outstanding	770.16	770.16	773.44	773.44	773.64	772.8
Working Capital	2,930	3,319	3,912	3,991	3,440	2,978
Book Value Per Share	8.34	8.57	8.43	8.23	7.51	6.97
Tangible Book Value	6,049	6,217	6,156	6,166	5,606	5,214
Tangible Book Value Per Share	7.85	8.07	7.96	7.97	7.25	6.75
Buildings	-	1,338	1,337	1,323	1,341	1,310
Machinery	-	1,107	1,087	1,028	978.12	922.81
Construction In Progress	-	386.46	333.85	331.62	285.01	203.08

Source: S&P Capital IQ. Standard template. Financial Sources.